Zika Virus: Hofbauer Cells & Fecal Transmission

1. Hofbauer Cells — What Are They?

• Immune surveillance and tolerance at the maternal-fetal interface
• Cytokine regulation (both pro- and anti-inflammatory)
• Villous development and angiogenesis
• Pathogen defense — ironically, also a target for certain viruses

2. Zika Virus (ZIKV) and Hofbauer Cells

How ZIKV Infects Hofbauer Cells

Why This Is Clinically Critical

• HBCs sit within chorionic villi, ideally positioned as a gateway between maternal blood and fetal circulation
• When ZIKV infects HBCs, it can disseminate to fetal endothelial cells and neural progenitor cells, leading to:
  • Microcephaly
  • Cortical thinning and neuronal apoptosis
  • Intracranial calcifications
  • Fetal growth restriction

Placental Pathology Due to ZIKV-Infected HBCs

• Hofbauer cell hyperplasia — a hallmark histological finding in ZIKV-infected placentas
• Villous stromal edema
• Trophoblast damage (though cytotrophoblasts are relatively more resistant than HBCs due to lower AXL expression)
• Increased pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) impairing fetal neurodevelopment further

Key Research Findings

• Quicke et al. (2016) demonstrated that HBCs are productively infected by ZIKV, supporting their role as a viral reservoir and transplacental conduit.
• Bayer et al. (2016) showed that term placental explants with abundant HBCs are permissive to ZIKV, while first-trimester placentas (with fewer HBCs) showed variable resistance — explaining why first-trimester infection carries the highest risk of fetal anomalies.
• ZIKV-infected HBCs produce less type I interferon than expected, allowing viral persistence.

3. Fecal Transmission of Zika Virus

Known Transmission Routes of ZIKV

Evidence for Fecal Shedding

• ZIKV RNA has been detected in stool/feces of infected patients, documented in multiple case reports and cohort studies.
• A notable case from 2016 (Roze et al.) described ZIKV RNA detected in feces, raising concern for a fecal-oral route.
• ZIKV RNA was detected in stool up to 2 weeks after symptom onset in some patients.

Mechanism of Fecal Shedding

1. ZIKV infects gastrointestinal epithelial cells and enteric neurons, which express AXL and other entry receptors.
2. Viral replication in the gut leads to shedding of viral particles into the intestinal lumen.
3. These particles are excreted in feces.

Is Fecal-Oral Transmission Confirmed?

• Not definitively confirmed as a functional route of human-to-human transmission yet.
• Detection of RNA ≠ infectious virus — viral viability in feces has not been robustly demonstrated.
• The WHO and CDC acknowledge fecal shedding but do not currently list fecal-oral as an established transmission route.
• However, given ZIKV's neurotropism and enteric cell permissiveness, it cannot be ruled out, especially in:
  • Immunocompromised individuals
  • Settings with poor sanitation

Public Health Implications

• Standard contact and enteric precautions are recommended when handling feces of ZIKV-infected patients in clinical settings.
• Shedding in feces adds to the concern about environmental contamination of water supplies in endemic areas.

Summary